Implanet SA - Asset Resilience Ratio
Implanet SA (ALIMP) has an Asset Resilience Ratio of 0.55% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2020)
This chart shows how Implanet SA's Asset Resilience Ratio has changed over time. Check how strategically is Implanet SA's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Implanet SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Implanet SA worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €93.00K | 0.55% |
| Total Liquid Assets | €93.00K | 0.55% |
Asset Resilience Insights
- Limited Liquidity: Implanet SA maintains only 0.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Implanet SA Industry Peers by Asset Resilience Ratio
Compare Implanet SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Implanet SA (2013–2020)
The table below shows the annual Asset Resilience Ratio data for Implanet SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 1.47% | €128.00K ≈ $149.65K |
€8.70 Million ≈ $10.17 Million |
+0.66pp |
| 2019-12-31 | 0.81% | €78.00K ≈ $91.19K |
€9.65 Million ≈ $11.28 Million |
-2.88pp |
| 2018-12-31 | 3.68% | €326.00K ≈ $381.13K |
€8.85 Million ≈ $10.35 Million |
-4.31pp |
| 2017-12-31 | 7.99% | €1.00 Million ≈ $1.17 Million |
€12.56 Million ≈ $14.69 Million |
+5.01pp |
| 2016-12-31 | 2.98% | €490.74K ≈ $573.72K |
€16.46 Million ≈ $19.24 Million |
-29.61pp |
| 2015-12-31 | 32.59% | €5.31 Million ≈ $6.21 Million |
€16.29 Million ≈ $19.04 Million |
+30.47pp |
| 2014-12-31 | 2.12% | €308.12K ≈ $360.22K |
€14.55 Million ≈ $17.02 Million |
-6.25pp |
| 2013-12-31 | 8.36% | €2.00 Million ≈ $2.34 Million |
€23.92 Million ≈ $27.97 Million |
-- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-… Read more